"The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group". Annals of Internal Medicine. 122 (8): 561–568. April 1995. doi:10.7326/0003-4819-122-8-199504150-00001. PMID7887548. S2CID24754081.
Scott G (March–April 2013). "The diabetic foot examination: A positive step in the prevention of diabetic foot ulcers and amputation". Osteopathic Family Physician. 5 (2): 73–78. doi:10.1016/j.osfp.2012.08.002. S2CID72816348.
United Kingdom Prospective Diabetes (UKPDS) Study Group (September 1998). "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group". Lancet. 352 (9131): 837–853. doi:10.1016/S0140-6736(98)07019-6. PMID9742976. S2CID7019505.
Viberti GC (November 1983). "Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy". The American Journal of Medicine. 75 (5B): 81–84. doi:10.1016/0002-9343(83)90257-7. PMID6673594.
Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E, Kellicut D, Sidawy AN (September 2006). "Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia". Annals of Vascular Surgery. 20 (5): 653–658. doi:10.1007/s10016-006-9055-6. PMID16741654. S2CID9028358.
Thornalley PJ (August 2005). "The potential role of thiamine (vitamin B1) in diabetic complications". Current Diabetes Reviews. 1 (3): 287–298. doi:10.2174/157339905774574383. PMID18220605.
Rabbani N, Thornalley PJ (July 2011). "Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy". Diabetes, Obesity & Metabolism. 13 (7): 577–583. doi:10.1111/j.1463-1326.2011.01384.x. PMID21342411. S2CID11763040.
Al-Maskari MY, Waly MI, Ali A, Al-Shuaibi YS, Ouhtit A (July 2012). "Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes". Nutrition. 28 (7–8): e23–e26. doi:10.1016/j.nut.2012.01.005. PMID22595450.
Mangoni AA, Jackson SH (May 2002). "Homocysteine and cardiovascular disease: current evidence and future prospects". The American Journal of Medicine. 112 (7): 556–565. doi:10.1016/s0002-9343(02)01021-5. PMID12015248.
Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA (May 2006). "Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering". Vascular Medicine. 11 (2): 101–109. doi:10.1191/1358863x06vm664oa. PMID16886840. S2CID8771566.
Rahimi R, Nikfar S, Larijani B, Abdollahi M (August 2005). "A review on the role of antioxidants in the management of diabetes and its complications". Biomedicine & Pharmacotherapy. 59 (7): 365–373. doi:10.1016/j.biopha.2005.07.002. PMID16081237.
Takiishi T, Gysemans C, Bouillon R, Mathieu C (June 2010). "Vitamin D and diabetes". Endocrinology and Metabolism Clinics of North America. 39 (2): 419–46, table of contents. doi:10.1016/j.ecl.2010.02.013. PMID20511061.
Muthian G, Raikwar HP, Rajasingh J, Bright JJ (May 2006). "1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis". Journal of Neuroscience Research. 83 (7): 1299–1309. doi:10.1002/jnr.20826. PMID16547967. S2CID71926561.
Gannagé-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (August 2003). "Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women". Journal of Endocrinological Investigation. 26 (8): 748–753. doi:10.1007/bf03347358. PMID14669830. S2CID30463402.
"The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group". Annals of Internal Medicine. 122 (8): 561–568. April 1995. doi:10.7326/0003-4819-122-8-199504150-00001. PMID7887548. S2CID24754081.
Pirart J (December 1977). "[Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)]". Diabète & Métabolisme. 3 (4): 245–256. PMID598565.
United Kingdom Prospective Diabetes (UKPDS) Study Group (September 1998). "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group". Lancet. 352 (9131): 837–853. doi:10.1016/S0140-6736(98)07019-6. PMID9742976. S2CID7019505.
Viberti GC (November 1983). "Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy". The American Journal of Medicine. 75 (5B): 81–84. doi:10.1016/0002-9343(83)90257-7. PMID6673594.
Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E, Kellicut D, Sidawy AN (September 2006). "Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia". Annals of Vascular Surgery. 20 (5): 653–658. doi:10.1007/s10016-006-9055-6. PMID16741654. S2CID9028358.
Thornalley PJ (August 2005). "The potential role of thiamine (vitamin B1) in diabetic complications". Current Diabetes Reviews. 1 (3): 287–298. doi:10.2174/157339905774574383. PMID18220605.
Rabbani N, Thornalley PJ (July 2011). "Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy". Diabetes, Obesity & Metabolism. 13 (7): 577–583. doi:10.1111/j.1463-1326.2011.01384.x. PMID21342411. S2CID11763040.
Al-Maskari MY, Waly MI, Ali A, Al-Shuaibi YS, Ouhtit A (July 2012). "Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes". Nutrition. 28 (7–8): e23–e26. doi:10.1016/j.nut.2012.01.005. PMID22595450.
Mangoni AA, Jackson SH (May 2002). "Homocysteine and cardiovascular disease: current evidence and future prospects". The American Journal of Medicine. 112 (7): 556–565. doi:10.1016/s0002-9343(02)01021-5. PMID12015248.
Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA (May 2006). "Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering". Vascular Medicine. 11 (2): 101–109. doi:10.1191/1358863x06vm664oa. PMID16886840. S2CID8771566.
Rahimi R, Nikfar S, Larijani B, Abdollahi M (August 2005). "A review on the role of antioxidants in the management of diabetes and its complications". Biomedicine & Pharmacotherapy. 59 (7): 365–373. doi:10.1016/j.biopha.2005.07.002. PMID16081237.
Afkhami-Ardekani M, Shojaoddiny-Ardekani A (November 2007). "Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients". The Indian Journal of Medical Research. 126 (5): 471–474. PMID18160753.
Takiishi T, Gysemans C, Bouillon R, Mathieu C (June 2010). "Vitamin D and diabetes". Endocrinology and Metabolism Clinics of North America. 39 (2): 419–46, table of contents. doi:10.1016/j.ecl.2010.02.013. PMID20511061.
Muthian G, Raikwar HP, Rajasingh J, Bright JJ (May 2006). "1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis". Journal of Neuroscience Research. 83 (7): 1299–1309. doi:10.1002/jnr.20826. PMID16547967. S2CID71926561.
Gannagé-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (August 2003). "Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women". Journal of Endocrinological Investigation. 26 (8): 748–753. doi:10.1007/bf03347358. PMID14669830. S2CID30463402.
"The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group". Annals of Internal Medicine. 122 (8): 561–568. April 1995. doi:10.7326/0003-4819-122-8-199504150-00001. PMID7887548. S2CID24754081.
Scott G (March–April 2013). "The diabetic foot examination: A positive step in the prevention of diabetic foot ulcers and amputation". Osteopathic Family Physician. 5 (2): 73–78. doi:10.1016/j.osfp.2012.08.002. S2CID72816348.
United Kingdom Prospective Diabetes (UKPDS) Study Group (September 1998). "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group". Lancet. 352 (9131): 837–853. doi:10.1016/S0140-6736(98)07019-6. PMID9742976. S2CID7019505.
Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E, Kellicut D, Sidawy AN (September 2006). "Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia". Annals of Vascular Surgery. 20 (5): 653–658. doi:10.1007/s10016-006-9055-6. PMID16741654. S2CID9028358.
Rabbani N, Thornalley PJ (July 2011). "Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy". Diabetes, Obesity & Metabolism. 13 (7): 577–583. doi:10.1111/j.1463-1326.2011.01384.x. PMID21342411. S2CID11763040.
Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA (May 2006). "Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering". Vascular Medicine. 11 (2): 101–109. doi:10.1191/1358863x06vm664oa. PMID16886840. S2CID8771566.
Muthian G, Raikwar HP, Rajasingh J, Bright JJ (May 2006). "1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis". Journal of Neuroscience Research. 83 (7): 1299–1309. doi:10.1002/jnr.20826. PMID16547967. S2CID71926561.
Gannagé-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (August 2003). "Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women". Journal of Endocrinological Investigation. 26 (8): 748–753. doi:10.1007/bf03347358. PMID14669830. S2CID30463402.